Ingevity Corporation
NGVT
$45.84
-$1.52-3.21%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -16.88% | -13.19% | -11.01% | -2.29% | 1.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.88% | -13.19% | -11.01% | -2.29% | 1.43% |
| Cost of Revenue | -21.24% | -11.65% | -4.84% | 5.75% | 9.40% |
| Gross Profit | -6.24% | -16.70% | -23.82% | -18.20% | -13.89% |
| SG&A Expenses | -9.46% | -12.62% | -17.91% | -11.74% | -7.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.50% | -11.79% | -6.85% | 2.79% | 6.81% |
| Operating Income | -3.48% | -19.95% | -29.18% | -23.48% | -19.42% |
| Income Before Tax | -5,202.97% | -526.89% | -332.47% | -157.05% | -103.75% |
| Income Tax Expenses | -2,140.43% | -468.03% | -293.81% | -162.27% | -108.10% |
| Earnings from Continuing Operations | -7,868.52% | -543.86% | -343.40% | -155.63% | -102.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7,868.52% | -543.86% | -343.40% | -155.63% | -102.55% |
| EBIT | -3.48% | -19.95% | -29.18% | -23.48% | -19.42% |
| EBITDA | -6.04% | -16.55% | -20.02% | -14.16% | -10.28% |
| EPS Basic | -6,107.70% | -549.72% | -350.18% | -158.18% | -103.46% |
| Normalized Basic EPS | -32.37% | -53.51% | -62.69% | -47.51% | -32.52% |
| EPS Diluted | -5,228.42% | -553.54% | -352.28% | -158.96% | -104.05% |
| Normalized Diluted EPS | -32.10% | -53.19% | -62.51% | -47.38% | -32.49% |
| Average Basic Shares Outstanding | -0.50% | -1.37% | -2.53% | -3.88% | -4.45% |
| Average Diluted Shares Outstanding | -0.81% | -2.08% | -3.20% | -4.39% | -4.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
